Firering Strategic Minerals: From explorer to producer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDerwent London Regulatory News (DLN)

Share Price Information for Derwent London (DLN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2,320.00
Bid: 2,306.00
Ask: 2,316.00
Change: 22.00 (0.96%)
Spread: 10.00 (0.434%)
Open: 2,304.00
High: 2,328.00
Low: 2,290.00
Prev. Close: 2,298.00
DLN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Property swap

11 Feb 2015 08:00

RNS Number : 5754E
Derwent London PLC
11 February 2015
 



 

 

 

 

11 February 2015

Derwent London plc ("Derwent London" / "the Group")

DERWENT LONDON AGREES PROPERTY SWAP TO BOOST FARRINGDON EXPOSURE AND FORMS WHITECHAPEL JOINT VENTURE

Derwent London plc has exchanged contracts with LaSalle Investment Management ("LaSalle"), to acquire a minimum 175-year long leasehold of 20 Farringdon Road, Clerkenwell EC1 in London's Tech Belt.

In return Derwent London will dispose of two properties: 22 Kingsway WC2 and Mark Square House EC2, and a 50% interest in a new joint venture at 9 and 16 Prescot Street E1 to LaSalle. The price of the acquisition is £88.0m before costs, and the combined disposal proceeds are £115.3m. Derwent London will receive the balance of £27.3m in cash before costs.

20 Farringdon Road is a prominent corner property, adjacent to the site of the new Farringdon Crossrail station and opposite 19 Charterhouse Street EC1, which the Group acquired in November 2013. The six-storey property totals 170,600 sq ft comprising 141,400 sq ft of offices, 5,700 sq ft ancillary space, 1,200 sq ft retail, and a 22,300 sq ft gym. The passing rent is £3.6m per annum or £3.2m per annum net of the 10% ground rent. The ground floor offices (26,200 sq ft) are let at a peppercorn with a break in December 2015. The average rent on the other office floors is c.£27 per sq ft with leases expiring between 2015 and 2022. The net initial yield is 3.4%, which reflects a capital value of £545 per sq ft after costs.

The acquisition has significant near term potential to raise the rental income, as well as representing a substantial development opportunity in the medium term.

The two outright disposals of 22 Kingsway WC2 (91,400 sq ft) and Mark Square House EC2 (61,700 sq ft) will raise £96.6m before costs, which is a10% uplift on December 2013 values. It also represents a premium to June 2014 values. The combined rent was £4.5m per annum, which represents a net initial yield to the purchaser of 4.4% (or a capital value of £670 per sq ft).

In addition both partners will take a 50% share in a joint venture being established to hold 9 and16 Prescot Street E1. These two properties have been sold to the joint venture for £37.4m which represents a net initial yield to the purchaser of 4.9% or £370 per sq ft. In the short term these properties are income producing, but longer term there are redevelopment opportunities across the whole site.

9 Prescot Street is a 98,500 sq ft office building, which following recent management activity is let to two tenants. Barts Health NHS Trust occupies the lower five floors, comprising 60,000 sq ft, on a five-year lease for a rent inclusive of service charge of £1.5m pa. The Co-operative Bank ("Co-op"), whose lease over the whole building was due to expire this year, now lease the top three floors. In total the Co-op occupy 36,600 sq ft, where the lease will break later this year. The joint venture intends to refurbish this space once it becomes available.

16 Prescot Street is an 8,800 sq ft restaurant let at £9 per sq ft. The lease expires in 2021.

John Burns, Chief Executive Officer, commented:

"We are pleased to have secured a major potential project adjacent to the site of Farringdon Crossrail station in the heart of Clerkenwell, an area where we already have substantial interests. In return we have sold two smaller properties, and have established a joint venture in Whitechapel. Both Clerkenwell and Whitechapel are being transformed by the impact of Crossrail and creative industry occupiers, and we look forward to working with our new partner, LaSalle Investment Management, to maximise these opportunities."

 

For further information, please contact:

Derwent London

Tel: +44 (0)20 7659 3000

 

 

John Burns, Chief Executive Officer

David Silverman, Director

Quentin Freeman, Head of Investor Relations

Brunswick Group

Tel: +44 (0)20 7404 5959

Simon Sporborg

Nina Coad

 

 

Notes to editors

 

Derwent London plc

Derwent London plc owns a portfolio of commercial real estate predominantly in central London valued at £3.7 billion as at 30 June 2014, making it the largest London-focused real estate investment trust (REIT).

 

Our experienced team has a long track record of creating value throughout the property cycle by regenerating our buildings via development or refurbishment, effective asset management and capital recycling.

 

We typically acquire central London properties off-market with low capital values and modest rents in improving locations, most of which are either in the West End or the Tech Belt. We capitalise on the unique qualities of each of our properties - taking a fresh approach to the regeneration of every building with a focus on anticipating tenant requirements and an emphasis on design.

 

Reflecting and supporting our long-term success, the business has a strong balance sheet with modest leverage, a robust income stream and flexible financing.

 

Landmark schemes in our portfolio of 5.7 million sq ft as at 30 June 2014 include Angel Building EC1, The Buckley Building EC1, White Collar Factory EC1, 1-2 Stephen Street W1, Horseferry House SW1 and Tea Building E1.

 

In December 2014 Derwent London topped the real estate sector for the fifth year in a row and was placed ninth overall in the Management Today awards for 'Britain's Most Admired Companies'. Also in 2014 the Group won the Property Week 'Developer of the Year' and the RICS London Commercial Award, and was shortlisted for awards by Architects' Journal, BCO, NLA and OAS. The Group was also awarded EPRA Gold for corporate and sustainability reporting.

 

For further information see www.derwentlondon.com or follow us on Twitter at @derwentlondon

 

Forward-looking statements

This document contains certain forward-looking statements about the future outlook of Derwent London. By their nature, any statements about future outlook involve risk and uncertainty because they relate to events and depend on circumstances that may or may not occur in the future. Actual results, performance or outcomes may differ materially from any results, performance or outcomes expressed or implied by such forward-looking statements.

No representation or warranty is given in relation to any forward-looking statements made by Derwent London, including as to their completeness or accuracy. Derwent London does not undertake to update any forward-looking statements whether as a result of new information, future events or otherwise. Nothing in this announcement should be construed as a profit forecast.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCURSWRVUAUAAR
Date   Source Headline
22nd Jul 20143:00 pmRNSDisposal
15th Jul 20145:35 pmRNSNotice of Results
11th Jul 20147:45 amRNSSuccessful Pre-Let to Freud Communications
1st Jul 20145:45 pmRNSTotal Voting Rights
11th Jun 201410:30 amRNSAdditional Listing
3rd Jun 20144:00 pmRNSDirector/PDMR Shareholding
3rd Jun 20144:00 pmRNSDirector/PDMR Shareholding
3rd Jun 20144:00 pmRNSDirector/PDMR Shareholding
3rd Jun 20144:00 pmRNSDirector/PDMR Shareholding
3rd Jun 20144:00 pmRNSDirector/PDMR Shareholding
3rd Jun 20144:00 pmRNSDirector/PDMR Shareholding
2nd Jun 20145:25 pmRNSTotal Voting Rights
30th May 20144:10 pmRNSResolutions of the 2014 Annual General Meeting
21st May 201411:00 amRNSBlocklisting Interim Review
16th May 20145:15 pmRNSResult of AGM
16th May 20143:00 pmRNSBondholders meeting
14th May 20144:55 pmRNSScrip Dividend Scheme
14th May 201412:30 pmRNSHolding(s) in Company
8th May 20147:00 amRNSInterim Management Statement
1st May 20144:00 pmRNSTotal Voting Rights
17th Apr 20149:00 amRNSDocuments available at NSM
14th Apr 20144:30 pmRNSDirector/PDMR Shareholding
14th Apr 20144:30 pmRNSDirector/PDMR Shareholding
14th Apr 20144:30 pmRNSDirector/PDMR Shareholding
14th Apr 20144:30 pmRNSDirector/PDMR Shareholding
14th Apr 20144:30 pmRNSDirector/PDMR Shareholding
14th Apr 20144:30 pmRNSDirector/PDMR Shareholding
4th Apr 20144:24 pmRNSDirector/PDMR Shareholding
4th Apr 20144:23 pmRNSDirector/PDMR Shareholding
4th Apr 20144:20 pmRNSDirector/PDMR Shareholding
4th Apr 20144:20 pmRNSDirector/PDMR Shareholding
4th Apr 20144:20 pmRNSDirector/PDMR Shareholding
4th Apr 20144:20 pmRNSDirector/PDMR Shareholding
2nd Apr 20149:29 amRNSTotal Voting Rights
28th Mar 201410:30 amRNSBlocklisting Interim Review
24th Mar 20147:00 amRNSSale of Jaeger House, 57 Broadwick Street W1
20th Mar 20142:00 pmRNSChange of auditor
19th Mar 20143:55 pmRNSHolding(s) in Company
17th Mar 201410:00 amRNSAdditional Listing
13th Mar 201410:00 amRNSHolding(s) in Company
27th Feb 20147:00 amRNSFinal Results
22nd Jan 20143:00 pmRNSHolding(s) in Company
22nd Jan 20141:15 pmRNSNotice of Results
9th Jan 20149:00 amRNSCompletion of £100m Private Placement
8th Jan 20142:45 pmRNSDirectorate Change
7th Jan 20149:00 amRNSDerwent London acquisition of 22 Kingsway WC2
20th Dec 20133:40 pmRNSHolding(s) in Company
16th Dec 20133:09 pmRNSHolding(s) in Company
6th Dec 20133:00 pmRNSHolding(s) in Company
27th Nov 20135:55 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.